The Safety, Tolerability, and Efficacy of DL-Lactic Acid Syrup (Tonsitin) in Children With Recurrent Tonsillitis : A Pilot Study
To evaluate Tonsitin (10% DL-lactic acid) safety, tolerability, and efficacy, as a treatment for recurrent tonsillitis (RT) in children. This is a clinical prospective, randomized, double blind pilot study, to evaluate the safety, tolerability and efficacy of Tonsitin in healthy children with RT. Safety evaluated in terms of adverse events (AEs), tolerability in terms of compliance, and efficacy in terms of tonsils' size and frequency of tonsillitis, and quality of life. The study included 51 children. The treatment regimen was tolerable among the participants. Six children experienced AEs, but mostly mild. Tonsil size declined in both groups, but these results did not reach statistical significance. Tonsillitis episodes' frequencies were random and not significant. Tonsitin treatment was found to be feasible in the clinical setup and was well tolerated, and appears to be safe. Study efficacy results did not reach statistical significance.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Clinical pediatrics - (2024) vom: 11. Jan., Seite 99228231222317 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Taha, Ahmed [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
10% DL-lactic acid syrup (Tonsitin) |
|---|
| Anmerkungen: |
Date Revised 11.01.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1177/00099228231222317 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366962922 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366962922 | ||
| 003 | DE-627 | ||
| 005 | 20240114234122.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/00099228231222317 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1256.xml |
| 035 | |a (DE-627)NLM366962922 | ||
| 035 | |a (NLM)38205711 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Taha, Ahmed |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Safety, Tolerability, and Efficacy of DL-Lactic Acid Syrup (Tonsitin) in Children With Recurrent Tonsillitis |b A Pilot Study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a To evaluate Tonsitin (10% DL-lactic acid) safety, tolerability, and efficacy, as a treatment for recurrent tonsillitis (RT) in children. This is a clinical prospective, randomized, double blind pilot study, to evaluate the safety, tolerability and efficacy of Tonsitin in healthy children with RT. Safety evaluated in terms of adverse events (AEs), tolerability in terms of compliance, and efficacy in terms of tonsils' size and frequency of tonsillitis, and quality of life. The study included 51 children. The treatment regimen was tolerable among the participants. Six children experienced AEs, but mostly mild. Tonsil size declined in both groups, but these results did not reach statistical significance. Tonsillitis episodes' frequencies were random and not significant. Tonsitin treatment was found to be feasible in the clinical setup and was well tolerated, and appears to be safe. Study efficacy results did not reach statistical significance | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 10% DL-lactic acid syrup (Tonsitin) | |
| 650 | 4 | |a recurrent tonsillitis | |
| 650 | 4 | |a tonsillar hypertrophy | |
| 700 | 1 | |a Yeheskeli, Eyal |e verfasserin |4 aut | |
| 700 | 1 | |a Gavriel, Haim |e verfasserin |4 aut | |
| 700 | 1 | |a Berkovitch, Matitiahu |e verfasserin |4 aut | |
| 700 | 1 | |a Mizrakli, Yuval |e verfasserin |4 aut | |
| 700 | 1 | |a Shlamkovitch, Natan |e verfasserin |4 aut | |
| 700 | 1 | |a Kohn, Elkana |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical pediatrics |d 1962 |g (2024) vom: 11. Jan., Seite 99228231222317 |w (DE-627)NLM000002127 |x 1938-2707 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:11 |g month:01 |g pages:99228231222317 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/00099228231222317 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 11 |c 01 |h 99228231222317 | ||